Dr. Stella Vnook is a biotech executive, founder, and investor with over 25 years of experience spanning pharmaceuticals, biotechnology, and healthcare commercialization. Dr. Vnook currently serves as Executive Chair and CEO of Kaida Biopharma, a women's oncology company advancing novel hormone-based therapies, with a lead focus on ovarian cancer, followed by expansion into endometrial and triple-negative breast cancers. Dr. Vnook is also the Founder and President of Oral BioLife, Inc., a regenerative medicine company advancing treatments for periodontal disease, and the Founder of ACG Corporate Architects™, where she builds and scales healthcare and life sciences companies. In addition, Dr. Vnook leads Aviva Ventures, an investment and venture platform focused on supporting and scaling innovative healthcare companies. Throughout her career, Dr. Vnook has led both early-stage and growth-stage organizations, with a focus on translating scientific innovation into commercially viable products across oncology, cell therapy, neuroscience, and diagnostics. Dr. Vnook is recognized for expertise in company formation, clinical strategy, and commercialization, and is a frequent speaker on healthcare innovation and the future of personalized medicine.